Spots Global Cancer Trial Database for untreated adult acute lymphoblastic leukemia

Every month we try and update this database with for untreated adult acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia	NCT00040690	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate vincristine sul... radiation thera...	16 Years -	National Cancer Institute (NCI)
Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia	NCT01132573	Acute Leukemias... Philadelphia Ch... Recurrent Adult... Untreated Adult...	entinostat clofarabine pharmacological... laboratory biom...	21 Years -	National Cancer Institute (NCI)
Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia	NCT00003230	Leukemia	paclitaxel	18 Years - 75 Years	Swiss Group for Clinical Cancer Research
S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00109837	Leukemia	filgrastim cyclophosphamid... cytarabine daunorubicin dexamethasone doxorubicin leucovorin mercaptopurine methotrexate mitoxantrone Asparaginase prednisone thioguanine vincristine radiation thera... allopurinol bactrim	18 Years - 64 Years	SWOG Cancer Research Network
VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies	NCT00070538	Leukemia Myelodysplastic...	cytarabine laromustine	18 Years -	National Cancer Institute (NCI)
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer	NCT00027820	Adult Acute Mye... Childhood Acute... Childhood Acute... Childhood Myelo... Childhood Renal... Chronic Myelomo... Clear Cell Rena... de Novo Myelody... Metastatic Rena... Previously Trea... Progression of ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Refractory Anem... Refractory Anem... Refractory Chil... Refractory Chro... Renal Medullary... Type 1 Papillar... Type 2 Papillar... Untreated Adult... Untreated Adult... Untreated Child...	Fludarabine Pho... Total-Body Irra... Peripheral Bloo... Nonmyeloablativ... Cyclosporine Mycophenolate M...	-	Fred Hutchinson Cancer Center
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia	NCT00002494	Leukemia Lymphoma	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... mesna methotrexate prednisone therapeutic hyd... vincristine sul... low-LET cobalt-... low-LET photon ...	15 Years -	Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia	NCT00040690	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate vincristine sul... radiation thera...	16 Years -	National Cancer Institute (NCI)
Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia	NCT00278330	Blastic Phase C... Recurrent Adult... Recurrent Adult... Refractory Anem... Relapsing Chron... Untreated Adult... Untreated Adult...	alvocidib vorinostat	18 Years -	National Cancer Institute (NCI)
VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies	NCT00070538	Leukemia Myelodysplastic...	cytarabine laromustine	18 Years -	National Cancer Institute (NCI)
DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia	NCT00899366	Leukemia	microarray anal... mutation analys... immunologic tec...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia	NCT00002531	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... mercaptopurine methotrexate mitoxantrone hy... prednisolone teniposide thioguanine vincristine sul... vindesine allogeneic bone... peripheral bloo... radiation thera...	15 Years - 65 Years	National Cancer Institute (NCI)
Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies	NCT01564277	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Contiguous Stag... de Novo Myelody... Noncontiguous S... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Adult... Stage I Adult B... Stage III Adult... Stage IV Adult ... Untreated Adult... Untreated Adult...	rasburicase allopurinol	18 Years -	Roswell Park Cancer Institute
Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer	NCT00064285	Leukemia	alvocidib imatinib mesyla...	18 Years -	Virginia Commonwealth University
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00482352	Untreated Adult... Untreated Child...	laboratory biom...	1 Year - 30 Years	Children's Oncology Group
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia	NCT00061945	Acute Undiffere... B-cell Adult Ac... B-cell Childhoo... L1 Adult Acute ... L1 Childhood Ac... L2 Adult Acute ... L2 Childhood Ac... Philadelphia Ch... Philadelphia Ch... Philadelphia Ch... T-cell Adult Ac... T-cell Childhoo... Untreated Adult... Untreated Child...	allopurinol cyclophosphamid... daunorubicin hy... vincristine sul... dexamethasone asparaginase filgrastim imatinib mesyla... methotrexate cytarabine trimethoprim-su... mercaptopurine leucovorin calc... alemtuzumab acyclovir laboratory biom... pharmacological...	15 Years -	National Cancer Institute (NCI)
Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia	NCT00275080	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Secondary Acute... Splenic Margina... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Grade... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Small... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Unspecified Adu... Untreated Adult... Untreated Adult...	vorinostat decitabine	18 Years -	National Cancer Institute (NCI)
Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant	NCT00469820	Leukemia Multiple Myelom...	autologous tumo... peripheral bloo...	18 Years - 70 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia	NCT01653613	Leukemia	DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymorphism an... reverse transcr... laboratory biom...	16 Years - 39 Years	National Cancer Institute (NCI)
Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia	NCT01581528	Leukemia	gene expression... cell culture pr... flow cytometry laboratory biom... metabolic asses...	-	Children's Oncology Group
Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase	NCT00383474	Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Blastic Phase Recurrent Adult... Recurrent Adult... Recurrent Disea... Untreated Adult... Untreated Adult...	Bortezomib Laboratory Biom... Tipifarnib	18 Years -	National Cancer Institute (NCI)
Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies	NCT00544466	Leukemia Myelodysplastic...	fludarabine pho... melphalan allogeneic hema... intensity-modul...	7 Years -	City of Hope Medical Center
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma	NCT00018954	Leukemia Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... doxorubicin hyd... etoposide ifosfamide mercaptopurine methotrexate prednisone vincristine sul... conventional su... radiation thera...	-	National Institutes of Health Clinical Center (CC)
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer	NCT00004061	Leukemia Lymphoma Oral Complicati...	filgrastim palifermin cyclophosphamid... etoposide ifosfamide peripheral bloo... quality-of-life... radiation thera...	18 Years - 65 Years	National Cancer Institute (NCI)
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia	NCT00002700	Leukemia Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate mitoxantrone hy... prednisolone prednisone therapeutic hyd... vincristine sul... allogeneic bone... autologous bone... radiation thera...	15 Years - 60 Years	European Organisation for Research and Treatment of Cancer - EORTC
Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia	NCT00499759	Depression Fatigue Leukemia Musculoskeletal... Psychosocial Ef...	Resting vitals Body Compositio... Timed Get-up an... Cardiorespirato... Handgrip evalua... Dynamic muscula...	18 Years - 60 Years	UNC Lineberger Comprehensive Cancer Center
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer	NCT00004061	Leukemia Lymphoma Oral Complicati...	filgrastim palifermin cyclophosphamid... etoposide ifosfamide peripheral bloo... quality-of-life... radiation thera...	18 Years - 65 Years	National Cancer Institute (NCI)
Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia	NCT00039130	Leukemia Lymphoma	filgrastim rituximab cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate prednisone vincristine sul... Allopurinol	16 Years -	Alliance for Clinical Trials in Oncology
Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia	NCT00321880	Fatigue Leukemia Psychosocial Ef...	therapeutic tou...	18 Years - 120 Years	Wake Forest University Health Sciences
Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma	NCT02293109	Contiguous Stag... Noncontiguous S... Stage I Adult L... Stage III Adult... Stage IV Adult ... Untreated Adult...	carfilzomib cyclophosphamid... vincristine sul... doxorubicin hyd... dexamethasone methotrexate cytarabine leucovorin calc... methylprednisol... rituximab laboratory biom...	18 Years - 64 Years	University of California, Davis
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01005758	Leukemia	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera...	18 Years - 50 Years	National Cancer Institute (NCI)
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia	NCT01653613	Leukemia	DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymorphism an... reverse transcr... laboratory biom...	16 Years - 39 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia	NCT00003700	Leukemia	G-CSF asparaginase cyclophosphamid... cytarabine daunorubicin hy... leucovorin calc... mercaptopurine methotrexate prednisone vincristine sul... Allopurinol	15 Years -	Alliance for Clinical Trials in Oncology
FR901228 in Treating Patients With Hematologic Cancer	NCT00024180	Leukemia Lymphoma	romidepsin	18 Years -	National Cancer Institute (NCI)
Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia	NCT00321880	Fatigue Leukemia Psychosocial Ef...	therapeutic tou...	18 Years - 120 Years	Wake Forest University Health Sciences
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00844298	Leukemia	Nilotinib+mVPD	15 Years -	Asan Medical Center
Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer	NCT00064285	Leukemia	alvocidib imatinib mesyla...	18 Years -	Virginia Commonwealth University
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia	NCT00133991	Leukemia Lymphoma	Filgrastim Rituximab Cyclophosphamid... Cytarabine Methotrexate Prednisone Hydrocortisone Vincristine Leucovorin	30 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00618501	Leukemia	cytarabine daunorubicin hy... etoposide imatinib mesyla... leucovorin calc... methotrexate prednisolone therapeutic hyd... vincristine sul... allogeneic hema...	15 Years -	National Cancer Institute (NCI)
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00618501	Leukemia	cytarabine daunorubicin hy... etoposide imatinib mesyla... leucovorin calc... methotrexate prednisolone therapeutic hyd... vincristine sul... allogeneic hema...	15 Years -	National Cancer Institute (NCI)
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia	NCT00002665	Leukemia Neutropenia Thrombocytopeni...	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide leucovorin calc... mercaptopurine methotrexate prednisone thioguanine vincristine sul... allogeneic bone... radiation thera...	15 Years - 65 Years	SWOG Cancer Research Network
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer	NCT00004132	Drug/Agent Toxi... Leukemia Lymphoma Multiple Myelom... Oral Complicati... Radiation Toxic...	filgrastim palifermin cyclophosphamid... etoposide ifosfamide quality-of-life... radiation thera...	12 Years - 65 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00558519	Leukemia	cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate pegaspargase thioguanine vincristine sul... radiation thera...	16 Years - 39 Years	Alliance for Clinical Trials in Oncology
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma	NCT00002766	Leukemia Lymphoma	dactinomycin sargramostim carmustine cyclophosphamid... cytarabine daunorubicin hy... doxorubicin hyd... etoposide mercaptopurine methotrexate mitoxantrone hy... pegaspargase prednisone vincristine sul... radiation thera...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia	NCT00816283	Leukemia	dasatinib vorinostat cytogenetic ana... gene expression... mutation analys... reverse transcr... flow cytometry laboratory biom...	18 Years -	City of Hope Medical Center
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01005758	Leukemia	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera...	18 Years - 50 Years	National Cancer Institute (NCI)
Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia	NCT00039130	Leukemia Lymphoma	filgrastim rituximab cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate prednisone vincristine sul... Allopurinol	16 Years -	Alliance for Clinical Trials in Oncology
Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia	NCT00458848	Leukemia	asparaginase daunorubicin hy... etoposide idarubicin imatinib mesyla... mercaptopurine methotrexate methylprednisol... mitoxantrone hy... prednisone vincristine sul... allogeneic hema... autologous hema... peripheral bloo... radiation thera...	15 Years - 60 Years	Gruppo Italiano Malattie EMatologiche dell'Adulto
Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720	NCT01004965	Leukemia	laboratory biom...	18 Years -	Alliance for Clinical Trials in Oncology
Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia	NCT00321880	Fatigue Leukemia Psychosocial Ef...	therapeutic tou...	18 Years - 120 Years	Wake Forest University Health Sciences
Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia	NCT00943709	Hyperglycemia Leukemia	insulin glargin... therapeutic ins...	18 Years -	Rutgers, The State University of New Jersey
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia	NCT00860574	Accelerated Pha... Adult Acute Lym... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Childhood Acute... Childhood Acute... Childhood Chron... Childhood Myelo... Chronic Myelomo... de Novo Myelody... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Secondary Myelo... Untreated Adult... Untreated Child...	treosulfan fludarabine pho... total-body irra... peripheral bloo... tacrolimus allogeneic bone... allogeneic hema... methotrexate	- 60 Years	Fred Hutchinson Cancer Center
Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01085617	Leukemia Mucositis Oral Complicati...	palifermin rituximab cyclophosphamid... cytarabine daunorubicin hy... etoposide fludarabine pho... imatinib mesyla... melphalan mercaptopurine methotrexate nelarabine pegaspargase vincristine sul... allogeneic hema... total-body irra...	25 Years - 65 Years	University College, London
DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia	NCT00899366	Leukemia	microarray anal... mutation analys... immunologic tec...	18 Years - 120 Years	Eastern Cooperative Oncology Group
R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia	NCT00004009	Leukemia	tipifarnib	18 Years - 120 Years	University of Maryland, Baltimore
Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia	NCT01424982	Accelerated Pha... Acute Lymphobla... Adult Acute Lym... B Acute Lymphob... Blast Phase Chr... Philadelphia Ch... Untreated Adult...	Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Doxorubicin Hyd... Laboratory Biom... Methotrexate Ponatinib Ponatinib Hydro... Prednisone Rituximab Vincristine Vincristine Sul...	18 Years -	M.D. Anderson Cancer Center
Sunitinib in Treating Patients With Idiopathic Myelofibrosis	NCT00387426	Accelerated Pha... Acute Undiffere... Adult Acute Lym... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Atypical Chroni... Blastic Phase C... Chronic Myelomo... Chronic Phase C... Mast Cell Leuke... Meningeal Chron... Primary Myelofi... Progressive Hai... Prolymphocytic ... Recurrent Adult... Recurrent Adult... Refractory Chro... Refractory Hair... Relapsing Chron... Secondary Acute... Stage I Chronic... Stage II Chroni... Stage III Chron... Stage IV Chroni... T-cell Large Gr... Untreated Adult... Untreated Adult... Untreated Hairy...	sunitinib malat...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia	NCT01156883	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... ifosfamide mercaptopurine methotrexate methylprednisol... prednisone thioguanine vincristine sul... vindesine	18 Years - 34 Years	Gruppo Italiano Malattie EMatologiche dell'Adulto

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: